secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempus AI, Inc. (TEM)
CIK:        0001717115
Form:       8-K
Filed at:   2024-11-05T23:59:59+00:00
Accession:  0001193125-24-251239
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempus AI to acquire Ambry Genetics for $375M cash plus ~4.84M shares
---------------------------------------------------------------------

- Acquisition of Ambry Genetics (genetic testing) for $375M cash + 4,843,136 TEM shares valued at ~$46.46/share avg VWAP.
- Debt financing from Ares: $200M term loan + $100M revolving credit facility to fund cash consideration and fees.
- Expected close in Q1 2025 subject to HSR clearance and other customary conditions.
- Seller (Konica Minolta's REALM IDx) provides limited indemnity; Tempus obtained buyside R&W insurance policy.
- Lock-up on 2,152,505 shares of stock consideration for one year; registration rights granted for stock consideration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1717115/000119312524251239/0001193125-24-251239-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1717115/000119312524251239/d907265d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-251239

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer